Sonoma Pharmaceuticals, Inc. SNOA
Set alert
1.10 USD 0.00 0.00%
At close · Nov 2
1.07 -0.03 -2.64%
After hours · Nov 2, 4:00 PM ET
1.05 Day range 1.15
0.85 52-week range 3.97
- YTD
- -69.78%
- 1 year
- -72.08%
- Open
- 1.08
- Prev close
- 1.10
- Mkt cap
- 5.27M
- Vol
- 42.24K
- Avg vol
- 107.76K
- EPS
- -1.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.15
- Forward P/E
- -1.49
- Beta
- 1.38
- Short ratio
- 0.22
- Inst. own
- 2.42%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 2.82
- 200-d avg
- 3.79
- 1y target
- 19.50
Analyst view
Consensus: none
Price target (mean) 19.50 +1672.7% upside
Now 1.10
- Target (low)
- 17.00
- Target (mean)
- 19.50
- Target (high)
- 22.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.60 | -0.60 – -0.60 | 0.00 | 0.0% | 4.06M | +29.4% | 1 |
| Next quarter | -0.60 | -0.60 – -0.60 | 0.00 | 0.0% | 4.44M | +29.1% | 1 |
| Current year | -2.80 | -2.80 – -2.80 | 0.00 | 0.0% | 15.47M | +21.5% | 1 |
| Next year | -1.20 | -1.20 – -1.20 | -2.80 | +57.1% | 19.67M | +27.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 5, 2023 | Ladenburg Thalmann | Initiated | — | Buy |
| Mar 6, 2018 | Maxim Group | Downgrade | Buy | Hold |
| Dec 28, 2017 | Benchmark | Initiated | — | Speculative Buy |
| Nov 10, 2017 | Maxim Group | Maintained | — | Buy |